Skip to content

Nuvation Bio NUVB Other Non-Current Assets

Other Non-Current Assets at other companies

Nuvalent, Inc. logo
Nuvalent, Inc.NUVL
$23.21M+20.6%
Immunome logo
ImmunomeIMNM
$5.36M+23.4%
ArriVent BioPharma, Inc. logo
ArriVent BioPharma, Inc.AVBP
$156K-11.4%
Arcus Biosciences logo
Arcus BiosciencesRCUS
$61M-14.1%
Tango Therapeutics logo
Tango TherapeuticsTNGX
$293K+29,200%
Summit Therapeutics logo
Summit TherapeuticsSMMT
$8.23M+98.6%

Where this comes from

Reported directly by Nuvation Bio in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.

The official record: Nuvation Bio’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Nuvation Bio's other non-current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Nuvation Bio's other non-current assets?
Nuvation Bio (NUVB) reported other non-current assets of $3.82M in Q1 2026.
How has Nuvation Bio's other non-current assets changed year-over-year?
Nuvation Bio's other non-current assets decreased by 42.2% year-over-year, from $6.62M to $3.82M.
What is the long-term trend for Nuvation Bio's other non-current assets?
Over 5 years (2020 to 2025), Nuvation Bio's other non-current assets has grown at a 85.3% compound annual growth rate (CAGR), from $348K to $7.61M.
What does other non-current assets mean?
Long-term assets not classified in specific categories — a catch-all for miscellaneous non-current assets.